Lyu Kangchen, Tan Baoying, Su Ziling, Xuan Jianwei
Health Economic Research Institute, School of Pharmacy, Sun Yat-Sen University Guangzhou China.
Laryngoscope Investig Otolaryngol. 2025 Mar 18;10(2):e70106. doi: 10.1002/lio2.70106. eCollection 2025 Apr.
Although image-guided system (IGS) is considered useful in endoscopic sinus surgery (ESS), its impact on clinical outcomes needs further evaluation. This study aimed to compare clinical outcomes in patients with chronic rhinosinusitis (CRS) undergoing ESS with or without IGS.
Two independent reviewers searched PubMed, EMBASE, Cochrane, CNKI, WanFang, and VIP to identify comparative clinical studies on clinical outcomes of ESS with or without IGS.
The primary outcome were total complications. Secondary outcomes were recurrence, revision surgery, blood loss, surgical time, and patient-reported outcomes. A meta-analysis was performed to calculate odds ratios (OR) and weighted mean difference (WMD).
A total of 16 studies were included with a total sample size of 3014 patients. Compared with non-IGS, total complications were less common in IGS group (OR = 0.52, 95% CI, 0.37 to 0.74, < 0.01), and recurrence rate and revision surgery rate in IGS group was also lower (recurrence rate: OR = 0.31, 95% CI, 0.18 to 0.52, < 0.001; revision surgery rate: OR = 0.59, 95% CI, 0.36 to 0.98, = 0.04). What is more, IGS could reduce intraoperative blood loss (WMD = -10.74 mL; 95% CI, -20.92 to -0.57; = 0.04) and surgical time (WMD = -6.25 min; 95% CI, -9.59 to -2.90, < 0.001).
Compared with non-IGS, IGS-assisted ESS was associated with a lower risk of total complications, recurrence, and revision surgery, and with a reduction of intraoperative blood loss and surgical time. These findings support the clinical use of IGS as an adjunct in ESS for CRS patients.
尽管图像引导系统(IGS)在内镜鼻窦手术(ESS)中被认为是有用的,但其对临床结局的影响仍需进一步评估。本研究旨在比较接受ESS的慢性鼻窦炎(CRS)患者使用或不使用IGS的临床结局。
两名独立的评审员检索了PubMed、EMBASE、Cochrane、中国知网、万方和维普,以确定关于ESS使用或不使用IGS的临床结局的比较临床研究。
主要结局为总并发症。次要结局为复发、翻修手术、失血量、手术时间和患者报告的结局。进行荟萃分析以计算比值比(OR)和加权平均差(WMD)。
共纳入16项研究,总样本量为3014例患者。与非IGS组相比,IGS组总并发症较少见(OR = 0.52,95%CI,0.37至0.74,P < 0.01),IGS组的复发率和翻修手术率也较低(复发率:OR = 0.31,95%CI,0.18至0.52,P < 0.001;翻修手术率:OR = 0.59,95%CI,0.36至0.98,P = 0.04)。此外,IGS可减少术中失血量(WMD = -10.74 mL;95%CI,-20.92至-0.57;P = 0.04)和手术时间(WMD = -6.25 min;95%CI,-9.59至-2.90,P < 0.001)。
与非IGS相比,IGS辅助的ESS总并发症、复发和翻修手术风险较低,且术中失血量和手术时间减少。这些发现支持将IGS作为CRS患者ESS的辅助手段临床应用。
3级。